Safety and tolerability Of Lysyl OxidAse InhibitoR (LOX) In the amelioration of acute and established scAr: a single centre Phase I study

Project Details

StatusFinished
Effective start/end date6/11/206/12/21

Funding

  • Pharmaxis Ltd: A$991,316.00